Galliprant for Dogs Side Effects: What Every Owner Should Know

Understanding Galliprant and Osteoarthritis in Dogs

Osteoarthritis (OA) is a progressive, degenerative joint disease affecting an estimated 20–25% of adult dogs and up to 80% of senior dogs over age 8. It occurs when cartilage cushioning the joints breaks down, leading to inflammation, pain, and reduced mobility. Galliprant (generic name: grapiprant) is a prescription non-steroidal anti-inflammatory drug (NSAID) specifically designed to target the EP4 receptor, which plays a central role in osteoarthritis pain and inflammation in dogs.

Unlike traditional NSAIDs that block COX enzymes broadly, Galliprant's targeted mechanism was designed to reduce certain side effects associated with long-term NSAID use. However, like all medications, Galliprant for dogs side effects can occur, and understanding them is critical for any owner managing a dog's chronic pain. This guide covers what to watch for, how side effects are managed, and when to seek immediate veterinary help.

Disclaimer: This article is for informational purposes only. Always consult your veterinarian before starting, adjusting, or stopping any medication for your dog.

What Is Galliprant and How Does It Work?

Galliprant (grapiprant tablets) is manufactured by Elanco and was FDA-approved in 2016 for the control of pain and inflammation associated with osteoarthritis in dogs. It belongs to a class called piprant NSAIDs and works by selectively blocking the prostaglandin E2 (PGE2) EP4 receptor — one of the primary pathways through which dogs experience OA pain.

Because it does not inhibit COX-1 or COX-2 enzymes the way drugs like carprofen (Rimadyl), meloxicam (Metacam), or deracoxib (Deramaxx) do, Galliprant was initially marketed as having a potentially improved safety profile for long-term use. According to the Merck Veterinary Manual, this selectivity may reduce gastrointestinal and renal risks, though post-market data continues to be monitored.

Galliprant is available in three tablet strengths: 20 mg, 60 mg, and 100 mg, and is dosed once daily at approximately 2 mg/kg (0.9 mg/lb) of body weight. It should be given with food to improve absorption and reduce GI upset.

Common and Serious Galliprant Side Effects in Dogs

Based on the FDA-approved labeling and post-market surveillance data, side effects of Galliprant range from mild and self-limiting to rare but serious. Below is a severity-organized checklist to help you monitor your dog.

Symptom Checklist: Galliprant Side Effects by Severity

Severity Level	Symptoms	Typical Onset	Action
Mild / Common	Soft stool or mild diarrhea	First 1–2 weeks	Monitor; ensure given with food; mention at next vet visit
Mild / Common	Decreased appetite	First 1–2 weeks	Try giving with a full meal; monitor weight weekly
Mild / Common	Occasional vomiting	First 1–2 weeks	Withhold next dose if vomiting repeats; call vet if >2 episodes in 24 hours
Moderate	Persistent diarrhea (3+ days)	Any time during treatment	Stop medication and contact your veterinarian
Moderate	Increased thirst and urination (polydipsia/polyuria)	Weeks to months	Schedule vet visit; may indicate renal changes
Moderate	Lethargy or behavioral changes	Variable	Discontinue and consult vet within 24–48 hours
Serious / Rare	Bloody or black tarry stool (melena)	Variable	Stop immediately; seek emergency veterinary care
Serious / Rare	Jaundice (yellowing of gums, eyes, skin)	Variable	Emergency — possible hepatotoxicity
Serious / Rare	Seizures or incoordination (ataxia)	Variable	Emergency veterinary care immediately
Serious / Rare	Sudden collapse or severe weakness	Variable	Emergency — possible acute renal or hepatic failure

In the pivotal field study supporting FDA approval, the most frequently reported adverse events were vomiting (approximately 8% of dogs), diarrhea (approximately 6%), and decreased appetite (approximately 4%). Serious adverse events were uncommon but included one case of suspected hepatopathy. Post-market reports submitted to the FDA have added isolated cases of renal insufficiency, particularly in dogs with pre-existing kidney disease or concurrent nephrotoxic drug use.

Risk Factors: Which Dogs Are More Vulnerable?

Diagnosing Problems: When Your Vet Suspects a Galliprant Reaction

If your dog develops symptoms while on Galliprant, your veterinarian will typically follow a structured diagnostic process to determine whether the medication is the cause and whether organ damage has occurred.

Baseline blood work is strongly recommended before starting Galliprant, and periodic monitoring (every 6 months for long-term use) is considered standard of care according to the American Veterinary Medical Association (AVMA) guidelines on NSAID use in companion animals.

Treatment Options if Side Effects Occur

If your dog experiences adverse effects from Galliprant, your veterinarian has several management strategies depending on severity. Here is a comparison of approaches:

Scenario	Treatment Approach	Expected Outcome	Estimated Cost
Mild GI upset (soft stool, single vomit)	Dose timing adjustment; administer with full meal; add probiotic (e.g., Purina FortiFlora or Nutramax Proviable)	Resolution in 3–7 days for most dogs	$15–$35 (probiotic)
Persistent vomiting/diarrhea	Discontinue Galliprant; short course of gastroprotectants (famotidine 0.5 mg/kg BID or omeprazole 1 mg/kg SID); bland diet for 3–5 days	Most dogs recover fully within 5–10 days	$25–$60 (medications) + $55–$95 (exam)
Elevated liver enzymes (mild, <3× normal)	Discontinue Galliprant; recheck blood work in 2–4 weeks; consider hepatoprotectant (Denamarin — SAMe + silybin)	Enzymes often normalize within 4–8 weeks if drug is stopped early	$120–$220 (recheck labs) + $35–$65/month (Denamarin)
Elevated kidney values (BUN/creatinine/SDMA)	Stop Galliprant immediately; IV or subcutaneous fluid therapy; renal diet transition; recheck in 48–72 hours	Variable — early detection improves prognosis; pre-existing CKD worsens prognosis	$200–$600 (fluids + hospitalization) + $120–$220 (labs)
GI ulceration / melena	Emergency hospitalization; IV fluids; injectable gastroprotectants (sucralfate, misoprostol); blood transfusion if severe anemia	Guarded to fair with aggressive treatment; survival depends on blood loss severity	$800–$3,000+ (emergency hospitalization)
Acute hepatopathy	Discontinue all NSAIDs; supportive care with IV fluids, hepatoprotectants, vitamin K1 if coagulopathy present	Guarded prognosis; recovery possible if caught early but some cases progress to liver failure	$500–$2,500+

Alternative Pain Management Options

If Galliprant is discontinued due to side effects, your veterinarian may recommend alternative OA pain strategies:

• Librela (bedinvetmab): A monoclonal antibody injection administered monthly by your vet that targets nerve growth factor (NGF). No NSAID-related GI or renal side effects. Cost: $65–$120 per injection depending on dog size.
• Adequan (polysulfated glycosaminoglycan): An injectable disease-modifying OA drug given as a series of intramuscular injections. Cost: $45–$75 per dose; loading series is 8 doses over 4 weeks.
• Gabapentin: An adjunct pain medication dosed at 5–15 mg/kg every 8–12 hours. Useful for neuropathic pain components. Low cost (~$10–$30/month).
• Amantadine: An NMDA receptor antagonist used as an adjunct for chronic pain wind-up. Dosed at 3–5 mg/kg once daily. Cost: $15–$40/month.
• Physical therapy and weight management: Underwater treadmill, therapeutic laser, and maintaining a body condition score (BCS) of 4–5/9 significantly reduce OA pain progression.

Prognosis and Long-Term Outlook

Side Effect Severity	Prognosis	Typical Recovery Timeline	Long-Term Considerations
Mild GI upset	Excellent	3–7 days after dose adjustment or discontinuation	Most dogs can be transitioned to alternative OA therapy without lasting effects
Moderate — persistent GI signs or mild lab abnormalities	Good to excellent	1–4 weeks with supportive care	Rechallenge with Galliprant not recommended; alternative pain management needed
Serious — renal insufficiency	Guarded to fair	2–8 weeks if caught early; may be permanent if advanced	Requires lifelong renal monitoring; CKD may progress independently of drug exposure
Serious — hepatopathy	Guarded	4–12 weeks if mild; may not resolve if significant necrosis	Liver function may remain compromised; avoid all hepatotoxic drugs going forward
Life-threatening — GI perforation or acute organ failure	Guarded to poor	Weeks to months; some cases do not survive	Survivors require lifelong organ-specific management and monitoring

Most dogs that experience mild side effects from Galliprant recover fully once the drug is discontinued. The key prognostic factor across all severity levels is early detection — dogs whose lab abnormalities are caught on routine monitoring before clinical symptoms appear have significantly better outcomes.

Home Care and Monitoring for Dogs on Galliprant

If your veterinarian has prescribed Galliprant, consistent home monitoring helps catch problems before they become serious:

Daily Monitoring Checklist

• Observe appetite at each meal — note any refusal or reduced intake
• Check stool consistency; photograph any abnormalities to show your vet
• Monitor water consumption — a sudden increase (more than 70 mL/kg/day is considered polydipsia) warrants a vet call
• Watch energy levels and willingness to move — paradoxical increase in lethargy may indicate the drug is not well tolerated
• Inspect gum color weekly — should be bubblegum pink; pale, gray, or yellow gums require immediate vet attention

Scheduled Veterinary Monitoring

• Baseline: CBC, chemistry panel, urinalysis before starting Galliprant
• 2-week recheck: Brief exam and lab panel to catch early adverse changes
• Every 6 months: Full blood work and urinalysis for dogs on long-term Galliprant therapy
• Any time symptoms change: Do not wait for the next scheduled appointment

Lifestyle Adjustments to Support OA Management

• Maintain ideal body weight — each pound of excess weight adds approximately 4 pounds of pressure on weight-bearing joints
• Provide orthopedic bedding (memory foam or elevated cot-style beds)
• Use ramps or stairs for furniture and vehicle access
• Provide non-slip flooring (yoga mats, area rugs) on hard surfaces
• Continue controlled, low-impact exercise — two 15–20 minute leash walks daily is often better than one long outing
• Consider omega-3 fatty acid supplementation (EPA/DHA at 75–100 mg/kg/day combined) for anti-inflammatory joint support

Cost Breakdown: Galliprant and Managing Side Effects

Understanding the financial commitment helps you plan for both routine use and potential complications.

Cost Category	Low Estimate	High Estimate	Notes
Galliprant monthly (20 mg tablets, small dog ~20 lb)	$55	$80	Price varies by pharmacy; ask about 90-day supply discounts
Galliprant monthly (100 mg tablets, large dog ~100 lb)	$130	$195	Compounding pharmacies may offer lower prices
Baseline blood work before starting	$150	$300	CBC + chemistry + urinalysis + SDMA
Bi-annual monitoring labs	$120	$250	Every 6 months for long-term use
Managing mild GI side effects	$40	$130	Exam fee + probiotics or gastroprotectant
Managing moderate organ-related side effects	$250	$700	Labs + hepatoprotectants or fluid therapy
Emergency treatment (severe reaction)	$800	$4,000+	Emergency hospitalization, transfusions, intensive care
Switching to Librela (monthly alternative)	$65	$120	Per injection, size-dependent

Pet insurance can offset significant costs. Most comprehensive policies (e.g., Trupanin, Healthy Paws, Nationwide) cover prescription medications and adverse drug reaction treatment, though pre-existing OA may be excluded. Average monthly premiums in 2026 range from $35–$85 depending on breed, age, and deductible structure.

Frequently Asked Questions About Galliprant Side Effects

Can Galliprant cause kidney failure in dogs?

While Galliprant's EP4-selective mechanism was designed to reduce renal risk compared to traditional NSAIDs, kidney injury has been reported in post-market surveillance. Dogs with pre-existing kidney disease, dehydration, or concurrent nephrotoxic medications are at higher risk. Baseline and periodic kidney function monitoring (BUN, creatinine, SDMA, urinalysis) is the best protective strategy.

How long does it take for Galliprant side effects to appear?

Mild GI side effects (vomiting, soft stool, appetite changes) typically appear within the first 1–2 weeks of treatment. More serious organ-related effects may develop over weeks to months, which is why ongoing lab monitoring is essential even if your dog seems fine.

Can I give Galliprant with other medications?

Galliprant should never be combined with other NSAIDs (carprofen, meloxicam, firocoxib, deracoxib) or corticosteroids (prednisone, dexamethasone, prednisolone). A washout period of at least 3–5 days (or longer for some drugs) is needed when switching between NSAIDs. Always disclose all medications and supplements to your veterinarian. Galliprant is generally considered compatible with gabapentin, tramadol, amantadine, and joint supplements, but your vet should confirm all combinations.

Is Galliprant safe for long-term use?

Galliprant is approved for long-term daily use in dogs with osteoarthritis, and many dogs tolerate it well for years. However, "safe" does not mean "risk-free." Long-term safety depends on regular veterinary monitoring, correct dosing, and prompt attention to any changes in appetite, thirst, stool quality, or energy levels.

What should I do if I miss a dose?

Give the missed dose as soon as you remember if it is still the same day. If it is close to the next scheduled dose, skip the missed dose and resume the regular schedule. Never double the dose to make up for a missed one.

Are there breeds that should avoid Galliprant?

There is no breed-specific contraindication listed on the FDA label. However, breeds predisposed to kidney disease (Bernese Mountain Dogs, Bull Terriers, Cavalier King Charles Spaniels, Shih Tzus) or liver disease (Doberman Pinschers, Cocker Spaniels, Labrador Retrievers with copper storage hepatopathy) may warrant extra monitoring. Discuss breed-specific risks with your veterinarian.

How does Galliprant compare to other NSAIDs for side effect risk?

Head-to-head comparative studies are limited. In its approval field study, Galliprant showed numerically lower rates of GI side effects compared to historical carprofen data, but direct statistical comparison is difficult due to different study designs. The FDA's Center for Veterinary Medicine continues to collect adverse event reports for all approved animal drugs. Your vet will consider your dog's individual health profile when selecting the most appropriate NSAID.

Managing osteoarthritis in dogs is a long-term partnership between you and your veterinary team. Galliprant can be a valuable tool for many dogs, but informed monitoring is what keeps it safe. Keep a medication log, attend every recheck appointment, and never hesitate to call your vet if something feels off — early intervention is always simpler, cheaper, and more effective than emergency treatment.